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A diverse cadre of metazoan transcription factors mediate repression by recruiting protein complexes
containing the SMRT (silencing mediator of retinoid and thyroid hormone receptor) or N-CoR (nuclear receptor
corepressor) corepressors. SMRT and N-CoR nucleate the assembly of still larger corepressor complexes
that perform the specific molecular incantations necessary to confer transcriptional repression. Although
SMRT and N-CoR are paralogs and possess similar molecular architectures and mechanistic strategies, they
nonetheless exhibit distinct molecular and biological properties. It is now clear that the functions of both
SMRT and N-CoR are further diversified through alternative mRNA splicing, yielding a series of corepressor
protein variants that participate in distinctive transcription factor partnerships and display distinguishable
repression properties.This review will discuss what is known about the structure and actions of SMRT, N-CoR,
and their splicing variants, and how alternative splicing may allow the functions of these corepressors to be
adapted and tailored to different cells and to different developmental stages.
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Worms, humans, and gene numerology
Genome-level sequence analysis has led to a recent and
surprising realization: relatively few genes are necessary
to produce multicellular organisms, and the difference in
gene number between nematodes and New Yorkers (or
Nebraskans for that matter) is quite modest [ Pennisi,
2003 ]. How can only 30,000 genes construct entities as
complex as human beings? One explanation originates
in a prior, equally unexpected discovery: multiple distinct
mRNAs can be generated from a single genetic locus
through alternative mRNA splicing. Alternative mRNA
splicing diversifies the functions of a single gene by
creating multiple protein variants, each possessing distinct
domains and distinct properties [ Stamm et al., 2005 ]. In
this manner a limited number of genetic loci have been
elaborated by evolution to perform a multitude of roles.
In this review we will describe recent revelations as to
how important transcriptional coregulators, the SMRT
and N-CoR corepressors, are customized, tailored, and
adapted through alternative mRNA splicing, and the
implications of this phenomenon for the regulation of
metazoan gene expression.
Bipolar transcription: manic repression
The corepressor story begins with the recognition that
many eukaryotic transcription factors can function both
as activators and as repressors.This ambidextrous
transcriptional control is most readily observed for the
nuclear receptors: transcription factors that bind to specific
hormone ligands, bind to specific DNA sequences and
regulate the expression of adjacent target genes. Many
members of the nuclear receptor family, including the
thyroid hormone receptors (TRs) and retinoic acid
receptors (RARs), repress target gene expression in the
absence of hormone ligand, yet activate target gene
expression in the presence of a hormone agonist [
Mangelsdorf et al., 1995 ]. Still additional nuclear
receptors, such as the estrogen and androgen receptors,
are neutral in the absence of hormone yet can be toggled
between repressive and activating states by the
alternative binding of antagonist or agonist hormone
ligands [ Liu et al., 2002; Schulz et al., 2002; Shang and
Brown, 2002;Wagner et al., 1998; Zhang et al., 1998 ].
Indeed, this type of pharmacologically-driven receptor
modulation is the molecular basis behind clinical
interventions in important diseases, such as the use of
the anti-estrogen tamoxifen to treat mammary cancers
(e.g. [ Keeton and Brown, 2005;Takimoto et al., 1999 ]).
Many other transcription factors, even those not regulated
by hormone, display a similar transcriptional dualism,
either repressing or activating gene expression depending
on DNA binding site, promoter context, cell type, and the
influence of various cell signaling pathways [ Privalsky,
2001; Privalsky, 2004 ].
A single transcription factor can display these bipolar
gene regulatory properties through its ability to
alternatively recruit auxiliary proteins denoted
corepressors and coactivators [ Glass and Rosenfeld,
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assortment of acetyl transferases, methyl transferases,
ATP-dependent chromatin remodeling complexes, and
Mediator subunits [ Lonard and O'Malley, 2005; Roeder,
2005 ]. Coactivators enhance transcription by covalently
modifying chromatin (i.e. changing the "histone code"),
by rendering the DNA template more accessible, and by
recruiting components of the general transcriptional
machinery to a target promoter [ Freiman and Tjian, 2003;
Jenuwein and Allis, 2001;Tsai and Fondell, 2004 ].
Corepressor complexes, conversely, contain a variety of
histone deacetylase activities, and thus can strip the
acetate activation marks from chromatin; some
corepressors also make inhibitory contacts with the
general transcriptional machinery and interfere with
assembly of the preinitiation complex [ Hu and Lazar,
2000; Jepsen and Rosenfeld, 2002; Privalsky, 2004;
Urnov et al., 2001 ]. A given transcription factor, by
physically exchanging corepressor complexes for
coactivator complexes, can convert from a repressor to
an activator of gene expression [ Glass and Rosenfeld,
2000; Perissi et al., 2004; Privalsky, 2004 ].
Corepressor paralogs and functional
parallels: SMRT and N-CoR
The extensive role of corepressors and transcriptional
repression in metazoan gene regulation has only recently
become appreciated.Two proteins, Nuclear Receptor
Corepressor (N-CoR) and Silencing Mediator of Retinoid
and Thyroid hormone Receptors (SMRT), serve as key
corepressors for an large assortment of different
vertebrate transcription factors, including the nuclear
hormone receptors, PLZF, c-Jun, SMADs, CBF-1, B-Myb,
Pit-1, ETO-1/2, MyoD, NF-κB, and BCL-6, among others
(Figure 1) [ Ordentlich et al., 2001; Privalsky, 2004 ].
N-CoR and SMRT are encoded by distinct genetic loci,
but are paralogs of one another and share a common
molecular architecture, form similar complexes with other
corepressor proteins, and exert overlapping biological
functions [ Ordentlich et al., 2001; Privalsky, 2004 ]. Both
N-CoR and SMRT operate by tethering to their
transcription factor partners and nucleating the assembly
of a larger, functional corepressor complex [ Ordentlich
et al., 2001; Privalsky, 2004 ]. SMRT and N-CoR tether
to nuclear receptors, for example, through a set of
C-terminal "CoRNR box" motifs (Figure 1) [ Hu and Lazar,
1999; Nagy et al., 1999; Perissi et al., 1999; Xu et al.,
2002 ]. A secondary hierarchy of corepressor subunits,
including histone deacetylases, TBL-1, TBLR-1, GPS-2,
and a number of other modulatory and effector proteins
are recruited through docking surfaces (repression
domains, RDs) located principally in the N-terminal and
central regions of SMRT and N-CoR (Figure 1) [
Ordentlich et al., 2001; Privalsky, 2004 ]. Significantly,
SMRT and N-CoR not only physically recruit, but can also
kindle the enzymatic activity of their associated histone
deacetylases [ Codina et al., 2005; Guenther et al., 2001
].
The generation of SMRT and N-CoR, and their
maintenance as distinct paralogs throughout the evolution
of the vertebrate lineage, implies that these two
superficially similar corepressors must mediate distinct
biological functions. Indeed, one important function, the
ability to interact with different transcription factor
partners, clearly differs. For example, TRs can interact
more strongly with N-CoR than with SMRT, whereas the
reciprocal appears true for RARs [ Zamir et al., 1997 ].
Differences in amino acid sequence within and flanking
the CoRNR box motifs help define these distinct
interactions [ Cohen et al., 2001; Hu and Lazar, 1999; Xu
et al., 2002 ]. Moreover, the prototypic N-CoR molecule
encodes three CoRNR box motifs (N1, N2, and N3)
whereas the prototypic SMRT encodes only two (S1 and
S2) (Figure 1), further differentiating the specificities of
these two paralogs for different nuclear receptors [ Cohen
et al., 2001; Makowski et al., 2003;Webb et al., 2000 ].
SMRT and N-CoR also differ in their response to kinase
pathways that regulate their function. SMRT is
phosphorylated in response to growth factor receptor/MAP
kinase cascades; this phosphorylation results in release
of SMRT from TRs, RARs, and PLZF, derepression of
target genes serviced by these transcription factors, and
the redistribution SMRT from the nucleus to the cytoplasm
[ Hong and Privalsky, 2000; Hong et al., 1998; Jonas and
Privalsky, 2004 ]. N-CoR, in contrast, is refractory to this
form of direct intervention by growth factor/ kinase
cascades, although N-CoR appears to be regulated
indirectly by cytokines through a MEKK1/TAB2
intermediate [ Baek et al., 2002 ]. Conversely, N-CoR,
but not SMRT, can be negatively regulated by Akt in the
control of the NF-κB transcriptional response [ Hermanson
et al., 2002 ]. Expression levels of SMRT and N-CoR
differ in different tissues and at different times in
development, indicating that organisms adapt their
corepressor repertoire for distinct biological purposes [
Jepsen et al., 2000 ].
Corepressor diversification through
alternative mRNA splicing: the search
for the “true” SMRT N-terminus
In addition to the evolutionary gene duplication and
divergence events that led to the generation of the N-CoR
and SMRT paralogs, a second, equally important source
of corepressor diversity arises from alternative mRNA
splicing.The first suggestion that SMRT might be
alternatively-spliced was foreshadowed by differences in
the predicted N-terminal SMRT sequence as published
by various rival laboratories [ Chen and Evans, 1995;
Chen et al., 1996; Ordentlich et al., 1999; Park et al.,
1999; Sande and Privalsky, 1996 ].Three SMRT species
differing in their N-terminal initiation sites, were identified,
denoted from longest to shortest as SMRTα (also known
as SMRTe), s-SMRT (originally denoted SMRT or
TRAC-2), and TRAC-1 (also known as C-SMRT) (Figure
1 and Figure 2).The longest version, SMRTα is roughly
colinear with the longest known N-CoR clone, and
encompasses a similar (but non-identical) set of
repression and transcription factor tethering domains
(Figure 2) [ Horlein et al., 1995; Ordentlich et al., 1999;
Park et al., 1999 ].The two smaller variants, s-SMRT and
TRAC-1, encompass overlapping C-terminal domains,
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Review Nuclear receptor corepressorsFigure 1. Schematic of the N-CoR and SMRT corepressors. The primary structure of the human N-CoR and murine SMRTα are sketched from
N- to C-terminus [Horlein et al., 1995; Ordentlich et al., 1995]. Codon numbering is indicated on top.The locations of the repression domains (RD1 to
RD4), the deacetylase activating domain (DAD), the conserved SANT motifs that include sites of histone interaction, and of the CoRNR box/nuclear
receptor interaction sites (N1, N2, and N3 in N-CoR verses S1 and S2 in SMRT) are indicated within each corepressor schematic [Ordentlich et al.,
2001].The initiation codons for the N-terminally truncated s-SMRT and Trac-1 polypeptides are shown as red arrows. Interaction sites for transcription
factors that utilize SMRT and/or N-CoR for repression are indicated in yellow, whereas interaction sites for additional components of the corepressor
complex or the general transcriptional machinery are shown in red.The actual sites of contact may be smaller than the experimentally mapped domains
shown, and not all interacting proteins have been proven to interact with both N-CoR and SMRT.
but lack some or most of the N-terminal
repression/cofactor docking sites found in SMRTα (Figure
2) [ Chen and Evans, 1995; Chen et al., 1996; Ordentlich
et al., 1999; Park et al., 1999; Sande and Privalsky, 1996
]. s-SMRT is able to repress when experimentally tethered
to a promoter, whereas TRAC-1 cannot repress and
operates in transfections as a dominant-negative inhibitor
of corepressor function [ Chen and Evans, 1995; Chen
et al., 1996; Sande and Privalsky, 1996 ]. SMRTα is well
documented as a physiologically relevant, widely
expressed splice variant that can mediate repression by
a wide spectrum of transcription factor partners.The
biological relevance of s-SMRT and TRAC-1 is less clear;
these N-terminal truncated variants may potentially
mediate a subset of the repression functions of SMRTα,
or may even serve to as "anti-corepressors" [ Chen et
al., 1996; Sande and Privalsky, 1996 ]. Unfortunately,
both the s-SMRT and TRAC-1 clones, as initially
published, display chimeric characteristics indicative of
a joining of sequences from normally separate
chromosomes [ Chen and Evans, 1995; Sande and
Privalsky, 1996 ]. It is possible that s-SMRT and TRAC-1
are the products of authentic, if uncharacterized
chromosomal rearrangements in the aneuploid cell lines
from which they were isolated, or they may simply be
artifacts created during generation of the corresponding
cDNA libraries. Nonetheless, mRNAs and/or
immunoreactive polypeptides approximating these
truncated SMRTs in length, and a cDNA possibly
encoding a version of N-CoR similar to TRAC-1, have
been detected in several contexts [e.g. [ Chen et al., 1996;
Cote et al., 2004; Hollenberg et al., 1996; Meng et al.,
2005 ]), and it is possible that these N-terminal
corepressor variants may ultimately prove of some
physiological significance.
Corepressor diversification through
alternative mRNA splicing: custom
fitting of SMRT and N-CoR to their
transcription factor partners
In contrast to the ambiguities as to the authentic SMRT
N-terminus, analysis of the effect of alternative mRNA
splicing on internal SMRT sequences has yielded
significantly more definitive and provocative results.The
first hints of this type of modification were embedded, but
little noticed, in the first two published sequences of
SMRT, which differed by the presence or absence of a
47 codon "insert" just downstream of the S1 receptor
interaction domain (Figure 2, highlighted in red) [ Chen
and Evans, 1995; Chen et al., 1996; Sande and Privalsky,
1996 ]. Genomic sequence subsequently confirmed that
this insert had all the characteristics of an alternative exon
(exon 44b; Figure 2), and mRNAs both possessing and
lacking this exon can be readily detected in EST data
bases from a broad variety of species and cell types [
Goodson et al., 2005; Malartre et al., 2004; Short et al.,
2005 ]. For lack of a better nomenclature, the SMRT
isoform lacking this exon was denoted SMRTτ (tau),
whereas the SMRTα isoform was defined as containing
this insert [ Goodson et al., 2005 ].The SMRTτ variant
retains many of the same biochemical and molecular
biological features seen for SMRTα but differs notably in
its affinity for different nuclear hormone receptors relative
to the SMRTα form [ Goodson et al., 2005 ].This is most
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Review Nuclear receptor corepressorsFigure 2. Alternative mRNA splicing of SMRT. The murine SMRTα exon/intron organization is depicted on top, with exons shown in black.The
locations of introns are indicated by white lines and numbered by base position within the mature mRNA.The encoded murine SMRTα protein is shown
below from N- to C- terminus. General features are as in Figure 1. Exonic sequences spliced out of the murine SMRTα sequence are indicated by black
or red backgrounds, by downward pointed triangles, and by a negative sign next to their ordinal number; exonic sequences inserted relative to the
murine SMRTα sequence are indicated by boxes below the main schematic, by upward pointing arrows, and by positive signs next to their ordinal
number [Goodson et al., 2005; Malartre et al., 2004; Short et al., 2005].The splicing event deleting exon 44b is also denoted SMRTτ [Goodson et al.,
2005].
clearly manifested as a much higher affinity of SMRTα
for TRs relative to SMRTτ, whereas both SMRTα and
SMRTτ have virtually equal affinities for RARs [ Goodson
et al., 2005 ].This result is consistent with the location of
this alternative exon immediately flanking the S1 CoRNR
box motif (Figure 2), and therefore in an appropriate
position to modulate the corepressor/nuclear receptor
interaction [ Cohen et al., 2001; Hu and Lazar, 1999; Xu
et al., 2002 ]. Ratios of SMRTα to SMRTτ differ in different
tissues, suggesting that organisms can adapt the receptor
specificity of the corepressor to the biological
requirements of different cell types [ Goodson et al., 2005;
Short et al., 2005 ].
Further mining of EST databases, combined with wet
laboratory dissections, has revealed that the C-terminal
region of SMRT is subject to an aggressive array of
alternative mRNA splicing events, many of which are
predicted to modify or adapt the interactions of SMRT
with its transcription factor partners (Figure 2) ([ Malartre
et al., 2004; Short et al., 2005 ], M. Goodson, unpublished
observations). Perhaps the most remarkable of these
additional splicing events introduces into SMRT a novel
exon (exon 37b) containing a third CoRNR box (indicated
in purple and blue in Figure 2); this generates a
(S3+S2+S1) SMRT variant closely resembling the
previously established (N3+N2+N1) N-CoR in its triple
CoRNR box valency [ Malartre et al., 2004; Short et al.,
2005 ]. Although first characterized for Xenopus, where
it is expressed in almost all adulttissues at equal levels
with (S2+S1) SMRTα, this trivalent SMRT species is also
expressed in a variety of vertebrates, including mice,
where it is observed primarily in brain ([ Malartre et al.,
2004; Short et al., 2005 ], and M. Goodson, unpublished
observations]. It remains to be established if the nuclear
receptor interaction properties of this newly recognized
(S1+S2+S3) SMRT resemble those of N-CoR, or if it
instead displays its own, idiosyncratic set of receptor
interactions and affinities. Still other C-terminal variants
of SMRT have been detected that lack the S1 CoRNR
box, or that modify SMRT sequences outside of the
CoRNR boxes themselves (typified by loss of exons 41,
42b, or 44 relative to the SMRTα epitome; Figure 2) [
Short et al., 2005 ]. A number of these alternative splice
variants differ in their abundance at different times of
development or in different tissues [ Malartre et al., 2004;
Short et al., 2005 ]. Although additional investigation will
be required to fully understand the biochemical and
biological properties of these newly recognized SMRT
variants, it appears safe to predict that these alternative
splicing events represent a mechanism by which cells
can custom tailor repression to specific subsets of
transcription factors and their target genes. In considering
the possibilities, it should be remembered that many
non-receptor transcription factors bind outside of the
CoRNR motifs employed by the nuclear receptors (Figure
1), and thus splicing events that do not impinge directly
on the S1, S2, or S3 domains may nonetheless alter the
ability of SMRT to interact with specific subsets of its
transcription factor repertoire.
Turning to the other corepressor paralog, we find that the
C-terminal domain of N-CoR is also modified by
alternative mRNA splicing (Figure 3). Although the
archetypic N-CoR contains three CoRNR boxes, early
studies presciently established the existence of an
alternatively spliced form of N-CoR, denoted RIP13Δ1,
that deletes the N3 box (Figure 3) [ Horlein et al., 1995;
Seol et al., 1996 ].Thus both SMRT and N-CoR are
expressed as variants possessing either two or three
nuclear receptor interaction domains.The absence or
inclusion of the third CoRNR box in N-CoR/RIP13Δ1 alters
the affinity of the corepressor for different nuclear receptor
partners. For example, "classical" (N3+N2+N1) N-CoR
displays unusually high affinity for TRs, and this has been
mapped to the cooperative actions of N3 and N2; in
contrast RIP13Δ1, limited to the N2 and N1 interaction
surfaces, has significantly lower affinity for TRs [ Cohen
et al., 2001; Makowski et al., 2003;Webb et al., 2000 ].
Conversely, the (N2+N1) RIP13Δ1 clone appears to
display a higher relative affinity for the Rev-Erb Aα, RVR,
and COUP-TFII orphan receptors than does the
(N3+N2+N1) form of N-CoR [ Bailey et al., 1997; Downes
et al., 1996 ]. A second alternative splice near the very
C-terminus of N-CoR, removing most of exon 45, has
been identified in mice (Figure 3); no function has yet
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of this N-CoR variant appear constant in a variety of
tissues [ Short et al., 2005 ]. Apart from these two
examples, alternative splicing events in the C-terminal
portion of N-CoR appear to be significantly less frequent
than in the equivalent regions of SMRT, perhaps
indicative of a less diverse evolutionary program for
N-CoR relative to SMRT [ Short et al., 2005 ].
In summary, both N-CoR and SMRT have their affinity
for different transcription factors adjusted "on the fly"
through mRNA splicing events that either add, remove,
or adjust the interaction surfaces on the corepressors.
Several additional layers of complexity should be
considered as to the potential effects of these splicing
events. Nuclear receptors typically bind to DNA as protein
homo- or heterodimers, with each receptor molecule
thought to contact one of the CoRNR boxes in the SMRT
or N-CoR corepressor [ Privalsky, 2004 ]).The ability of
a given corepressor splice variant to recognize a given
receptor dimer may therefore depend not only on the
identity of each receptor in the dimer, but also on the
orientation and spacing of the receptors as they assemble
on a given target promoter (e.g. [ Zamir et al., 1997 ]). It
is also conceivable, if not yet experimentally proven, that
interactions with different transcription factors might be
able to induce different allosteric states in SMRT and
N-CoR so as to produce distinct functional outcomes;
these allosteric effects, if they occur, might differ for the
different SMRT splice variants. Finally, it should be noted
that the C-terminal domain of these corepressors not only
tethers SMRT and N-CoR to their transcription factor
partners, but also binds a number of other proteins of
incompletely understood function (e.g. Sharp, Figure 1),
and is an important site of post-translational modifications
that regulate corepressor function [ Hermanson et al.,
2002; Hoberg et al., 2004; Hong and Privalsky, 2000;
Jonas and Privalsky, 2004; Shi et al., 2001; Zhou et al.,
2001 ]. At least several of the alternative mRNA splicing
events discussed here may prevent, enhance, or
otherwise alter the recruitment of these additional proteins
and/or the effects of these regulatory modifications.
Corepressor diversification through
alternative mRNA splicing:
modifications of the SMRT and N-CoR
repression domains
In contrast to the extensive splice diversity discovered in
the C-terminal domain of SMRT, there are somewhat
fewer documented examples of alternative exon utilization
within the N-terminal repression domains of either SMRT
or N-CoR (putting aside the unresolved tale of s-SMRT
and TRAC-1). One interesting corepressor variant that is
well documented in this regard is SMRTβ, which by
excising exons 2 to 6 has lost repression domain 1 and
deleted potential interaction surfaces for mSin3, SAP30,
and TBL/R-1 (Figure 1 and Figure 2) [ Ordentlich et al.,
1999 ]. SMRTβ displays weaker repression properties in
transfection assays than does SMRTα, and if
overexpressed can paradoxically enhance RAR-mediated
gene expression and promote hormone-responsiveness
in retinoid-resistant leukemias [ Cote et al., 2004;
Ordentlich et al., 1999 ]; SMRTβ may be mediating these
positive transcriptional effects by counteracting the
stronger repression functions of SMRTα present in the
same cells, or more heretically, alternative splicing may
confer on SMRTβ genuine coactivator capabilities.
Looking further down the corepressor sequence, exon
19 of SMRT is also subject to alternative splicing,
corresponding to a region flanking repression domain 2
(Figure 2) ([ Short et al., 2005 ] and M. Goodson,
unpublished data].This alternative use of exon 19 may
represent a species difference rather than a
developmentally-regulated splicing event and its functional
consequences are not known [ Short et al., 2005 ]. More
extensively described in the literature is a splicing variant
of N-CoR, denoted RIP13a, that lacks exon 28 and
therefore a portion of repression domain 3 (Figure 3) [
Muscat et al., 1998; Seol et al., 1996 ].The loss of exon
28 of N-CoR removes sequences that have been
implicated (to varying degrees of confidence) as
interaction sites for mSin3, TFIIB, and/or the class II
histone deacetylases HDAC4 and 5 (compare Figure 1
and Figure 3) [ Ordentlich et al., 2001; Privalsky, 2004 ].
The repression properties of RIP13a therefore might be
expected to differ from those of N-CoR, particularly on
different promoters or in different cell contexts; this
prediction remains to be experimentally verified. Notably,
a nearby, but not-quite identical location in SMRT is also
subject to an alternative splicing event that, in the mouse,
introduces an insert from exon 25b into the published
SMRTα sequence [ Short et al., 2005 ]; as with RIP13a
the SMRT exon 25b variant appears likely to possess
modified repression properties, although this has not been
experimentally documented.
Additional splicing events may eventually be discovered
within the N-terminal repression domains of SMRT and
N-CoR that have remained undetected thus far due to
the 3' bias of the current EST data bases. Nonetheless,
it appears clear that alternative splicing is particularly
diverse in the C-terminal portion of SMRT, the region
containing the bulk of the known transcription factor
interaction sites, rather than in the more N-terminal
regions responsible for assembly of the remainder of the
corepressor holo-complex. In fact, many of the alternative
mRNA splicing events that do map within the N-terminal
two-thirds of SMRT and N-CoR encompass not only
known repression domains, but also impact tethering
surfaces for MyoD, Pit-1, PLZF, BCL-6, and/or ETO,
additional members of the transcription factor cohort that
utilize SMRT and N-CoR to mediate repression (Figure
1).
The data to date, therefore, favor a particularly prominent
role for mRNA splicing in defining and diversifying the
“afferent” targeting of SMRT (and N-CoR) to particular
subsets of transcription factor partners, and a lesser role
in modifying the “efferent” transcriptional repression
properties of the corepressor complex once recruited to
a promoter.
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Review Nuclear receptor corepressorsFigure 3. Alternative mRNA splicing of N-CoR. The human N-CoR exon/intron organization is depicted on top, with exons shown in black and
the locations of introns indicated by white lines and numbered as to their base positions within the mature mRNA.The encoded human N-CoR protein
is shown below from N- to C- terminus. General features are as in Figure 1. Exonic sequences spliced out of the human N-CoR sequence are indicated
by black backgrounds, by downward pointed triangles, and by a negative sign next to their ordinal number [Horlein et al., 1995; Malartre et al., 2004;
Seol et al., 1996; Short et al., 2005].The splicing event that removes exon 28 has also been denoted RIP13a; the splicing event that removes exon
37b has also been denoted RIP13Δ1 [Seol et al., 1996].
Where to next?
Clearly the crucial future task will be to fully define the
specific functions of each of the spliced variants alluded
to in this overview. Good progress has recently been
achieved in one key aspect of this goal: cataloging which
spliced forms are expressed in different species, in
different tissues and at different times in development [
Goodson et al., 2005; Malartre et al., 2004; Short et al.,
2005 ]. Detailed characterizations of the biochemical and
biological properties of the individual SMRT and N-CoR
are also in progress, but will need to further expanded
both in vitro and in vivo.The reader browsing this
overview will undoubtedly (and justifiably) propose still
another crucial objective: the development of a practical
and definitive nomenclature to describe the various
corepressor variants. It is evident that the current
nomenclature has evolved to be both confusing and
awkward. A unified and rationale approach to naming the
different spliced variants will be essential. One
suggestion: retain N-CoR and SMRT to distinguish the
two paralogs, but further identify the various spliced forms
originating from each locus by a simple numerical
nomenclature (e.g. SMRT-1 and SMRT-2 instead of
SMRTα and SMRTβ; N-CoR-1 and N-CoR 2 instead of
N-CoR and RIP13Δ1.
In conclusion, SMRT, and to a lesser extend, N-CoR have
joined the ranks of a flourishing horde of vertebrate gene
products whose functions are elaborated, adjusted, and
custom-fitted by alternative mRNA splicing. In looking
backward, it is essential to re-examine much of the data
already generated on corepressor function in light of this
new found diversity, making mental note of which spliced
variant was examined for each study, and evaluating
which variant yielded which result. In looking forward, a
most interesting and productive future appears to lie
ahead as the properties and biological roles of the various
spliced corepressors are revealed.
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